Liquid Biopsy’s Role in Marker Identification: An Interview With Dr. Martin Filipits

Artificial Intelligence in Lung Cancer: Opening New Avenues for Detection, Diagnosis, and Prognostication

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

#LCSM Chat Topic 6/4/2020: #ASCO20 Roundup for #LungCancer

Lung Cancer Considered - Episode XXV - Mar 16, 2020 Dr. Marty Edelman Speaks With IASLC President Dr. Tetsuya Mitsudomi

Gustave Roussy’s New Leadership

Fred Hutchinson’s New President, Director

Grappling with Coronavirus (SARS-CoV-2)

Histologic Transformation From NSCLC to SCLC: A Mechanism of Resistance to Osimertinib and Other Agents Targeting EGFR Mutations

Member Story: Dr. Shengxiang Ren

Member Story: Dr. Amy Moore

Member Stories: Dr. Ross Soo